论文部分内容阅读
AIM To evaluate addition of boceprevir to peginterferon/ribavirin (PR) in Russian patients with chronichepatitis C virus (HCV).METHODS: Treatment-naive (TN) and treatmentexperienced(TE) patients (who had failed priortreatment with PR for ≥ 12 wk) with chr